The next step in NeuroRehabilitation
EksoNR is a robotic exoskeleton specifically designed to be used in a rehabilitation setting to progress neurorehab patients so they can walk out of the device and back into their communities. As the first exoskeleton FDA-cleared for acquired brain injury, stroke, and spinal cord injury, EksoNR offers the industry’s most natural gait, re-teaching the brain and muscles how to properly walk again.
DATA CAPTUREView session-specific walking time, distance, and speed, securely saved to a secure, cloud-based dashboard for easier analytics.
POSTURE SUPPORTEksoNR helps patients bear only their own weight with proper postural alignment so you can maximize treatment time.
SMARTASSIST SOFTWARECustomize motor support for various impairment levels, from full assistance to patient-initiated movement, in both swing and stance phases of walking.
ADAPTIVE GAIT TRAININGSensors and software continuously monitor and regulate leg movement to minimize compensatory gait patterns.
CLINICIAN CONTROLSet training targets and modify assistance levels in real time for each leg, independently, based on patient goals and session feedback.
PRE-AMBULATORY TOOLSEksoNR includes PreGait: a suite of programs to help patients balance, weight shift, squat, and step in place before walking.
GET A DEMO
Try it to believe it.
How will your neurorehabilitation program benefit from EksoNR? Speak to one of our experts to learn more.
Not all exoskeletons are created equally.
Some exoskeletons are designed to be used as an assistive device for patients with a spinal cord injury and provide 100% of the power needed to walk. Aside from being the only exoskeleton FDA-cleared for ABI, EksoNR also is truly a rehab tool for physical therapists to challenge their patients, requiring active participation known to drive brain plasticity.
Lead the way in NeuroRehab.
EksoNR promotes proper posture and the most natural gait, so therapists can focus on treatment. The high, rigid back and various progressive modes make Ekso the ideal solution for ABI and stroke patients just beginning to walk.
Gait training in Ekso improves functional balance outside of the device in people with motor incomplete SCI.
Including Ekso gait training during rehabilitation improves patient gait speed outside of the device at discharge compared to admission.
Research shows that Ekso gait training improves walking distance outside of the device for people with stroke and motor incomplete SCI at discharge, when compared to patients rehabilitated without Ekso.
Backed by data from over 40 industry-leading research partners.
EksoNR is designed for clinicians, by clinicians. With more than 1,800 patients participating in 105 investigator-led clinical studies, Ekso is the most widely-studied exoskeleton for rehabilitation. Learn how Ekso enhances patient experiences and functional outcomes across the continuum of care.
Over 300 devices are in 30+ countries worldwide. More than 30% of centers with Ekso have more than one device.
Request a demo to see how EksoNR can benefit your practice.
Ekso is the only exoskeleton designed specifically by clinicians for clinicians and features software incorporating early mobility tools and independent walking support.
EksoNR is the new generation of EksoGT. To learn more about EksoNR and it’s new features, watch our “What’s New” video.
Request a demo to see EksoNR in your practice.
Ekso fits patients under 220 pounds and between 5′ and 6’4″.
Ekso comes with two sets of rechargeable lithium ion batteries that allow for continuous use.
Ekso Bionics exoskeletons are only available for patients from 5′ to 6′ 4″. Please contact Customer Relations for more information.
No, Ekso is only available in certified rehabilitation centers. Find a center near you with our interactive map.